FLT3 inhibitor lestaurtinib plus chemotherapy for newly diagnosed KMT2A-rearranged infant acute lymphoblastic leukemia: Children’s Oncology Group trial AALL0631
Published Online: 2021-02-23
Journal: LeukemiaLoading...
Authors: Andrew J. Carroll•Cindy Wang•Donald Small•Elizabeth A. Raetz•Joanne M. Hilden•John A. Kairalla•Lia Gore•Meenakshi Devidas•Michael J. Borowitz•Mignon L. Loh•Naomi J. Winick•Nyla A. Heerema•Patrick A. Brown•Stephen P. Hunger•Wanda L. Salzer•William L. Carroll•ZoAnn E. Dreyer
